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Background: The increase in antimicrobial resistance is of worldwide concern. Surrogate tracers attempt to
simulate microbial transmission by avoiding the infectious risks associated with live organisms. We evaluated silica
nanoparticles with encapsulated DNA (SPED) as a new promising surrogate tracer in healthcare.
Methods: SPED and Escherichia coli were used to implement three experiments in simulation rooms and a
microbiology laboratory in 2017–2018. Experiment 1 investigated the transmission behaviour of SPED in a predefined
simulated patient-care scenario. SPED marked with 3 different DNA sequences (SPED1-SPED3) were introduced at 3
different points of the consecutive 13 touch sites of a patient-care scenario that was repeated 3 times, resulting in a
total of 288 values. Experiment 2 evaluated SPED behaviour following hand cleaning with water and soap and alcohol-
based handrub. Experiment 3 compared transfer dynamics of SPED versus E. coli in a laboratory using a gloved finger
touching two consecutive sites on a laminate surface after a first purposefully contaminated site.
Results: Experiment 1: SPED adhesiveness on bare skin after a hand-to-surface exposure was high, leading to a
dissemination of SPED1–3 on all consecutive surface materials with a trend of decreasing recovery rates, also reflecting
touching patterns in concordance with contaminated fingers versus palms. Experiment 2: Hand washing with soap and
water resulted in a SPED reduction of 96%, whereas hand disinfection led to dispersal of SPED from the palm to the
back of the hand. Experiment 3: SPED and E. coli concentration decreased in parallel with each transmission step – with
SPED showing a trend for less reduction and variability.
Conclusions: SPED represent a convenient and safe instrument to simulate pathogen spread by contact transmission
simultaneously from an infinite number of sites. They can be further developed as a central asset for successful
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Background
The increasing spread of antimicrobial resistance and
the burden of healthcare-associated infections represent
substantial threats to patient health and life [1–3].
Healthcare workers’ (HCW) hands play a key role in
transmission of pathogens through bi-directional ex-
change of microbes between hands and surfaces, [4, 5]
especially considering that hand hygiene performance is
commonly substandard in almost all healthcare settings
despite widely accepted concepts and guidelines [6, 7]. A
recent head-camera-aided study uncovered that many
more opportunities for microbe transmission might exist
in acute healthcare than anticipated based on more trad-
itional hand hygiene observation methods [8–10]. Tra-
cing events leading to microbial transmission, however,
is difficult, especially using living microorganisms. Surro-
gate tracers may therefore provide a safer and easier
means to increase our understanding of transmission
pathways. Prior studies have attempted to trace trans-
mission events using microbial surrogates, [11–16] and/
or DNA [11, 17–21]. Use of microbial surrogates is lim-
ited to benign organisms, like MS2 phage, and therefore
limits their widespread use in transmission studies. DNA
transmission behaviour is unlikely to mimic that of mi-
croorganisms. Cauliflower mosaic virus DNA, [11, 17–
21] bacteriophages, and fluorescent lotion have been
used to this end in the past, [11–16, 19, 22].
The use of surrogates with physiochemical properties
more similar to microorganisms may allow simulating
transmission events without the need for microbial con-
tamination. Silica nanoparticles with encapsulated DNA
(SPED) of known nucleotide sequences have been estab-
lished by Paunescu et al. in order to create inert
surrogate tracers that serve to track the presence and
distribution of biological and chemical entities (e.g.
wastewater, milk, pesticides) [23–26]. Forming part of
daily meals of many people through seafood, grains, veg-
etables and broadly utilized in the food industry, silica
has been acknowledged as “safe” by the U.S. Food and
Drug Administration 50 years ago [27]. In medicine, e.g.
in medical imaging, silica nanoparticles are equally
widely used and investigations of their biological degrad-
ability and clearance has been conducted [27].
Thus, we investigated the behaviour of SPED as poten-
tial surrogate tracers for microbial transmission path-
ways in health care. More specifically, we aimed to
explore their transmission pattern in patient care pro-
cesses, to study the consequences of hand hygiene ac-
tions on SPED, and to contrast transfer dynamics of
SPED with those of E. coli.
Methods
Silica particles with encapsulated DNA
The synthesis and characterization of SPED was con-
ducted according to Paunescu et al. [23] (Fig. 1) First,
per batch, 4x4ml of silica nanoparticles (50 mg/ml in iso-
propanol) were surface functionalised in 4 separate fal-
con tubes by adding 40 μg of N-trimethoxysilylpropyl-N,
N,N- trimethylammonium chloride (TMAPS; 50% wt in
methanol) and stirred at 900 rounds per minute (rpm).
for 12 h at room temperature. The trimethylammonium
on the surface gave the silica particles a positive surface
charge. For DNA adsorption on the surface a 2 ml batch
of corresponding annealed DNA molecules was added to
200 ml ultrapure MilliQ (mQ) water (150 ng dsDNA/μl,
Nanodrop). Of the previously TMAPS functionalised
Fig. 1 Scheme of synthesis of SPED and analysis with qPCR quantification. Legend: TMAPS, N-trimethoxysilylpropyl-N,N,N- trimethylammonium
chloride; TEOS, tetraethyl orthosilicate
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particles, 0.4 g were added to the solution and the batch
was shaken for 10 s. Subsequently, 4 μl TMAPS were
added, the batch was shaken and then sonicated for 20 s.
Next, 62.5 μl of tetraethyl orthosilicate (TEOS) (≥99.0%,
Aldrich) were added and the batch was shaken for 5 h.
In a next step, 10 ml isopropanol and 5.9 ml TEOS were
mixed with 484.1 ml mQ water before adding it to the
previous mixture. The batch was then stirred at 600 rpm
for 4 days. To demonstrate the potential of multi-
tracing, three different batches were produced, each con-
taining a unique DNA sequence. The three particle
batches named SPED1, SPED2 and SPED3 had a hydro-
dynamic size of 218 ± 80 nm, 144.6 ± 46 nm and 173.4 ±
82 nm and a DNA loading of 21 μg, 23 μg, and 26 μg
dsDNA/mg of particles, respectively. The suspension
used for our experiments was prepared by diluting the
particles to 0.1 mg/ml or 1 mg/ml in mQ water + 10%
glycerine. We used glycerine to increase the probability
of transfers in our experiments according to preliminary
data showing higher transfer rates in the presence of gly-
cerine (data not shown). Glycerine is viscous and there-
fore increases the stickiness of the test suspension,
simulating the adhesive function of bacterial appendages
called pili.
Escherichia coli bacterial culture
Standard procedures were used to cultivate bacterial cul-
tures. Escherichia coli was cultured overnight in tryptic
soy broth (TSB; Sigma-Aldrich, St. Louis, Missouri,
USA). An aliquot of 2 ml of the bacterial cell culture was
triple washed by spinning down the E. coli culture in a 2
ml microcentrifugation tube (Eppendorf AG, Hamburg,
Germany) for 5 min at 3500 rpm. After each cycle, the
supernatant TSB was removed, and the bacterial culture
resuspended in 1 ml phosphate-buffered saline (PBS).
The obtained bacterial concentration was 108 CFU/ml.
To prevent further bacterial growth during transfer ex-
periments, microcentrifugation tubes were stored tem-
porarily on ice.
Study procedures
We conducted three experiments to investigate the be-
haviour of SPED in a simulated care scenario (Experi-
ment 1), while performing hand hygiene (Experiment 2),
and comparing SPED transfer dynamics with those of E.
coli (Experiment 3).
Experiment 1 - SPED transmission characteristics in a
simulated care scenario
We defined a simulated patient care scenario featuring
an examination stretcher with bed rails, a privacy screen,
and an infusion stand with two infusion bags. A patient
actor (henceforth patient) and a HCW trained as a phys-
ician (MS; henceforth HCW) conducted the following
actions in chronological order: closing a door using the
door handle (stainless steel), moving the privacy screen
(polyvinylchloride), elevating the bed rail (polypropyl-
ene), auscultating the patient’s chest with a stethoscope
(polyvinylchloride, PVC), taking the patient’s radial pulse
(bare skin), checking pupil reactivity while pulling up
the patient’s upper eyelid (bare skin), and changing the
infusion bag (polyolefin) (Fig. 2). Two video cameras po-
sitioned in a 90° angle on adjacent walls (GoPro® Hero 4
Black edition, GoPro Inc., San Mateo, CA) recorded the
scene simultaneously to monitor the sequence.
The scenario featured 13 experimentally pre-defined
hand-to-surface exposures, of which 10 were fomites and
3 were patient skin. The sites were chosen according to
our observational experience in healthcare settings as be-
ing habitual [8]. We marked swabbing areas of 1x3cm on
each of the 13 sites. The sites and both hands and fingers
of the HCW were swabbed prior to every simulation to
demonstrate they were free of SPED. The swabbing tech-
nique included with 20% glycerine solution premoistened
sterile cotton swabs (Naturaline Wattestäbchen, Steinfels
Swiss, Winterthur, Switzerland) that were rolled three
times over the area and then stored in a 2ml microcentri-
fugation tube at room temperature. This swabbing pro-
cedure applied to all following swabs in our experiments.
We inoculated three of the 13 sites with 0.2 ml of the
SPED test suspensions (1 mg/ml) and left to air dry for
5 min, namely the door handle with SPED1, the bed rail
with SPED2, and the left forearm of the patient with
SPED3 (Fig. 2). We decided to use three different initial
deposition sites with three SPED with distinct DNA
codes to test the parallel application and recovery of dis-
tinguishable SPED batches in the same healthcare sce-
nario. Throughout the entire simulated care scenario,
the patient was laying on his back on the examination
stretcher with his bare arms placed beside him without
contact to his body or the examination stretcher. Subse-
quently, the HCW actor performed the care scenario
while exclusively touching the 13 marked sites in a nat-
ural way. Once the simulation scenario was concluded,
we swabbed the 13 marked test areas as well as both of
the HCW’s palms and the fingers of her dominant right
hand, resulting in 48 specimens overall. After the experi-
ment, the microcentrifugation tubes were immediately
transported to the laboratory for processing.
The experiment was repeated three times on different
days and in different simulation rooms, each, referred to
as ‘runs’. The repetitions were to add validity to the
findings.
Experiment 2 - effect of hand hygiene action on SPED
concentration
We tested the impact of hand disinfection with alcohol-
based handrub and hand washing using soap and water
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on SPED skin concentration. Three groups of five partic-
ipants, each, were formed: a control group (CTRL), a
hand disinfection group (DISINF), and a hand washing
group (WASH). First, swabs were taken from the right
thenar of each participant to demonstrate no SPED were
present. Subsequently, a previously marked area of
2x2cm on the palmar side of the right thenar of each
participant was inoculated with 0.2 ml of the SPED1 test
solution (0.1 mg/ml). The fluid was dispensed over the
palms of both hands by rubbing both hands against each
other for 10 s. Once dry, swabs were taken from the pre-
viously marked area of the right thenar of each person,
and additionally from the dorsal hypothenar of DISINF
participants to test for dispersal by rubbing hands with
alcohol-based handrub.
CTRL participants held both their hands in the air
without any contact for 1 min. DISINF participants per-
formed hand hygiene according to the norm EN1500
using 3 ml of a commercially available alcohol-based
handrub (80% Ethanol with 1% Glycerine, B. Braun
Medical AG, Sempach, Luzern, Switzerland). WASH
participants washed their hands for 30 s with common
soap (Liquid Soap®, Sterisol AB, Vadstena, Sweden) and
water using the norm EN1499 procedure. The right the-
nar of all participants – and additionally the dorsal
hypothenar in DISINF participants – were swabbed
again after the non-contact waiting time in the CTRL
group and hand hygiene actions in the DISINF and
WASH group. Thereafter the test tubes were immedi-
ately transported to the laboratory for analysis.
Experiment 3 – transmission dynamics of SPED compared
with Escherichia coli
We analysed transmission tendencies of E. coli and SPED.
Prior to the experiment, a piece of laminate (melamine resin)
was rinsed with 70% ethanol, wiped with a sterile cloth and
allowed to air dry. Forty series of four squares of 2x2cm were
defined. The four squares were marked as origin surface
(ORIGS), 1st transfer surface (1TS), 2nd transfer surface
(2TS) and control surface (CTRLS), respectively. Next, sam-
ples of the surface and gloves (GLOVES) were taken by ei-
ther rinsing the surface with 100 μl of PBS or by cutting off
the glove’s index fingertip and adding it to a 1.5ml micro-
centrifugation tube filled with 100 μl of PBS to prove sterility.
Then, 20 μl of the E. coli solution was spread onto ORIGS,
and with intervals of 2min, onto CTRLS. The 2-min interval
allowed for continuous sampling of surfaces with identical
times between surface inoculation and subsequent sampling.
A two-step transmission was performed from ORIGS➔ 1TS
➔ 2TS by pressing the gloved index finger onto the corre-
sponding areas in that order. Samples were taken as de-
scribed above. The CTRLS served as a reference for the
number of E. coli or nanoparticles recovered from an inocu-
lated surface in the absence of a transfer event, and so not
part of the transfer. This procedure was repeated until there
were 20 replicates. The same procedure was reproduced for
20 replicates with 20 μl of the SPED solution (0.1mg/ml).
Quantification of SPED
To quantify the amount of DNA particles from each
swab after having performed the experiments, the cotton
Fig. 2 SPED deposition and screening sites in the patient care simulation in Experiment 1. Legend: 1-13, hand-to-surface exposures (1, door
handle; 2, privacy screen; 3, bed rail; 4&5, stethoscope; 6, left forearm; 7, eyelid; 8, infusion bag valve; 9&10, infusion bags; 11, bed rail; 12, privacy
screen; 13, right forearm. , SPED1 introduction (door handle); , SPED2 introduction (bed rail); , SPED3 introduction (patient
forearm); , transmission pathway with numbers representing the consecutive hand-to-surface exposures
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swab was placed in a 2 ml microcentrifugation tube
(Eppendorf AG, Hamburg, Germany) with 200 μl of mQ
water (Fig. 1). Each sample was ultrasonicated for 1 min
and vortexed for 10 s. To release the DNA from the sil-
ica coating, 1%vol of a highly diluted solution of buffered
oxide etch (BOE) with 0.03 wt% ammonium hydrogen
difluorid (NH4FHF, pure, Merck) and 0.02 wt% ammo-
nium fluoride (NH4F, puriss., Sigma-Aldrich, St. Louis,
Missouri, USA) were added to the sample. The resulting
suspension was then analysed by quantitative PCR
(LightCycler® 96) in a multiplex setup with three
sequence-specific fluorescent probes (SPED1: Hex,
SPED2: Texas Red, SPED3: FAM). All three fluorescent
probes could be detected simultaneously and allowed to
quantify each particle separately. The qPCR total reac-
tion volume was 12.5 μl consisting of 2.5 μl sample solu-
tion, 0.2 μl of each primer (3x forward and reverse),
0.125 μl of each probe (Microsynth AG) and Mastermix
2x (GoTaq® Probe, Promega). The qPCR program con-
sisted of a preincubation step for 600 s at 95 °C, followed
by a 2-step cycling for 15 s at 95 °C and for 60 s at 56 °C.
For quantification, a dilution series with known concen-
tration of particles was performed.
Sampling of Escherichia coli
Once the transfer procedures were completed, the sam-
ples were processed within 2 h. For sampling, the areas
contaminated with E. coli were rinsed with 100 μl of
PBS, which was then added to a further quantity of
100 μl of PBS in a 1.5 ml micro-centrifugation tube, and
vortexed. As for gloves (Nitrile latex free, LLG Labware,
Meckenheim, Germany), the index fingertip was cut off
after performing the transmissions, placed in a 1.5 ml
micro-centrifugation tube containing 200 μl of PBS and
subsequently vortexed. Aliquots of 100 μl of undiluted
specimen solution and 100 μl from 1:10–1:100′000 dilu-
tions were plated onto TBX Agar (Sigma-Aldrich, St.
Louis, Missouri, USA) and incubated at 36 ± 1 °C for 24
h.
Statistical analysis
Descriptive analysis of our data in Experiment 1 and 2
was performed with Microsoft® Excel® 2016. To estimate
the detection limit of the nanoparticles in our experi-
ments, we used the Method Detection Limit (MDL).
The MDL is defined as “the minimum measured con-
centration of a substance that can be reported with 99%
confidence that the measured concentration is distin-
guishable from method blank results.” [28] Values that
are below MDL are considered to be negative, values
higher than the limit as positive. The MDL was calcu-
lated as the mean concentration of the blank samples
plus three times the standard deviation.
For Experiment 3, test statistics including t-test were
conducted with R Statistical Software (version 3.6.0, R
foundation, Vienna, Austria). We defined transfer per-
cent as the fraction of E. coli or SPED recovered from
1TS, 2TS, and glove as a percentage of the seeded inocu-
lum recovered from the surface by swabbing, defined by
CTRLS.
Results
Experiment 1 - SPED transmission characteristics in a
simulated care scenario
According to the video analysis, the sequence of touched sur-
faces was maintained as scheduled for all runs. Overall, we
collected 96 swabs, each analysed for the three different
DNA sequences, resulting in 288 values. All 39 control swabs
on the 13 test sites for the three scenario runs before SPED
were negative. Equally, none of the swabs tested positive for
a given SPED type ahead of its deposition site in the care se-
quence (Fig. 3). For runs 1, 2 and 3, the MDL determined
from the recovered sample for SPED1 was 1.49− 7mg/ml;
3.70− 7mg/ml, 9.95− 8mg/ml, for SPED2, 1.80− 8mg/ml;
5.20− 9mg/ml; 3.75− 9mg/ml and for SPED3 4.24− 8mg/ml,
6.74− 8mg/ml; 1.25− 8mg/ml, respectively. Accordingly, over-
all, the number of positive results among all sites except the
deposition site and hands were 26 of 36 (72.2%) for SPED1,
28 of 30 (93.3%) for SPED2, and 8 of 21 (38.1%) for SPED3.
As for hands, right hand fingers revealed positive SPED re-
sults in 9 of 9 (100%), right hand palm in 6 of 9 (66.6%) and
left-hand palm in 2 of 9 (22.2%). Annex Table 1 shows the
proportion of all sites with positive SPED results. Detection
rates for the tracers varied among the touch-sites. Consist-
ently positive samples were found on the left and right fore-
arm of the patient, on the infusion bag valve, and on HCW’s
fingers. No differences were found in detectability regarding
the material on which the test suspension was deposited.
Experiment 2 - effect of hand hygiene procedure on SPED
concentration
All samples taken before applying SPED were negative.
The mean SPED1 DNA-concentration before and after
the experiment are presented in Annex Table 2. This cor-
responds to a 24% increase of SPED concentration for
CTRL, a reduction of 17% on the thenar and 25,670% in-
crease on the back of the hand for DISINF, and a reduc-
tion of 96% for WASH (Fig. 4).
Experiment 3 – transmission dynamics of SPED compared
with Escherichia coli
In total, 40 two-step transfers were conducted, 20 for E.
coli and 20 for SPED. Samples taken from gloves and
surface prior to the experiment were negative. The re-
sults are displayed in Annex Table 3 and Fig. 5.
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Discussion
We explored SPED as a promising agent to trace micro-
bial transmission in healthcare.
First, we were able to establish the suitability of SPED
to trace the transmission pathways of microbes in a sim-
ulated care scenario featuring a typical sequence of
hand-to-surface exposures. SPED concentration showed
decreasing trends with consecutive touched surfaces
downstream of their deposition site with consistently
negative upstream results. This is also the proof that
parallel recovery of SPED marked with different DNA
can be distinguished when applied in a healthcare envir-
onment. Importantly, they also exhibited discriminative
quantitative recovery patterns on hands and surfaces
Fig. 3 Detection of SPED1–3 on environmental and patient body sites and healthcare worker’s hands in Experiment 1. Legend: red/green/blue, 13
test sites of SPED1-3; yellow, healthcare workers’ hands; blue line, MDL minimal detection limit; , introduction of SPED1, SPED2 and
SPED3, respectively
Fig. 4 SPED1 skin concentration before and after hand cleaning procedures in Experiment 2. Legend: Disinfection, hand cleansing with alcohol-
based handrub; Washing, washing hands with soap and water; Control, no hand hygiene action; Error bars = Standard deviation
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reflecting the way objects were touched, i.e. with the
whole hand vs with fingertips only. The markers SPED1 –
initially deposited on the door handle - and SPED2 – ini-
tially deposited on bed rail 1 - were transmitted from their
deposit site to the palm of the HCW’s right hand and fin-
gers, and subsequently spread onto almost all surfaces ex-
cept eyelid and one of the two infusion bags that were
manipulated with fingertips. In contrast, the initial depos-
ition site of SPED3 – the left forearm of the patient – was
naturally touched by the HCW’s right hand fingers, which
resulted in an transmission to and recovery from consecu-
tive contact-sites that were touched by fingers only, i.e.
opposite forearm and infusion valve (Fig. 3). These find-
ings suggest that SPED could be used for a detailed under-
standing of transmission pathways in healthcare settings
with high special resolution, especially benefitting from
the possibility to use identifiable SPED in parallel and
avoid the problem of contamination in case of repeated
investigations in the same environment.
Second, in Experiment 2, we found that hand washing
with soap and water resulted in a nearly complete re-
moval of SPED from hands and thus ideally simulated
the mobilisation and dilution of microorganisms. In con-
trast, hand cleaning with alcohol-based handrub led to
the dispersion of SPED to the back of the hands. This is
the main shortcoming of SPED as a surrogate for bac-
teria and viruses that are destroyed by alcohol-based
handrub and effective surface disinfectants. It would be
desirable to develop the SPED tracer system further to
mitigate this flaw. At best, inertia against disinfectants
simulates the behaviour of partially inert
microorganisms such as spores (e.g. Clostridioides diffi-
cile) and non-enveloped virus (e.g. Norovirus) [29, 30].
The persistence of SPED in the environment can be seen
as another shortcoming that is, however, counterba-
lanced by the fact that SPED are marked by known
DNA-sequences per batch and thus, can be distin-
guished with each experiment run.
Third, and most importantly, SPED showed a nearly par-
allel decrease in concentration on surfaces compared to E.
coli in the head-to-head two-step transmission Experiment
3. By comparing transmission behaviour of SPED to those
of E. coli we found similarities in transfer with SPED exhi-
biting a trend to a lower decrease from one consecutive
surface to the other. This suggests that, when used as surro-
gate markers in real healthcare settings, transmission will
be rather over- than underestimated.
Previous studies have evaluated the use of harmless
surrogate tracers to simulate contact transmission path-
ways of potential pathogens in healthcare settings [11–
22]. These studies employed four surrogate markers,
namely DNA sequences of the cauliflower mosaic virus
DNA, [11, 17–21] bacteriophage MS2, a non-pathogenic
non-enveloped RNA virus, [11–16] and fluorescent
agents [13, 14, 16, 19, 22]. Some of these studies com-
pared fluorescent agents against MS2 bacteriophages
[13, 14, 16] or against cauliflower virus DNA [19]; or
used the two viral DNA markers in parallel [11]. Only
one of these studies compared the behaviour of cauli-
flower virus DNA and MS2 bacteriophage against C. dif-
ficile spores and found a similar environmental
transmission behaviour, [11] as did we in our
Fig. 5 Log10 percent transfers for the original, 1TS, 2TS, and GLOVES in Experiment 3. Legend: ORIGS, origin surface; 1TS, first surface touched
after the origin surface; 2TS, surface touched after 1TS; GLOVES, nitrile disposable glove index finger tested after all three surfaces have
been touched
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comparison between SPED and E. coli. Two studies used
visible fluorescent and flashlight reflective markers, re-
spectively, as part of an educational intervention on per-
sonal protective equipment handling and MS2
bacteriophages as outcome measure [15, 16]. These
studies all show an impressively widespread transmission
of surrogate markers across the healthcare setting in a
short interval of time, even if one considers that their
persistence in the environment might be longer than
viral or bacterial pathogens.
We used video to verify the correct execution of the
experimentally predefined hand-to-surface exposure se-
quence in a simulated care scenario. One study assessed
personal protecive equipment handling quality by video
and related it to transmission of MS2 bacteriophage and
fluorescent liquid [13]. Two studies outside of healthcare
settings estimated the risk of bacterial cross-
contamination in farming work with human excreta by
combining videography with environmental microbial
contamination data into a stochastic-mechanistic simu-
lation of bacterial transmission [31, 32].
In contrast to other methods to investigate pathogen
transmission in healthcare settings, using SPED has sev-
eral advantages. First, silica particles are easy to handle,
and their management requires only little specialised ex-
pertise. The equipment for the analysis, i.e. qPCR analy-
sers, are common equipment in hospital microbiology
laboratories. Second, SPED are widely available, safe, and
inexpensive. As an example, the raw materials for three
repetitions of the Experiment 1 amounted to ~ 200
USD, including DNA, primers and other reagents. The
costs of SPED are mainly determined by the price of the
synthetic DNA amplicon, which currently equals 500
USD for 100 mg of newly synthesized DNA. Third, the
physical characteristics of SPED, such as electric charge,
hydrophobic versus hydrophilic properties, size and
weight can be modified to match those of pathogens
[33–35]. Forth, and most importantly for a clinical appli-
cation, the fact that SPED solutions with multiple DNA-
codes can be applied and analysed by PCR simultan-
eously provides the opportunity to study an almost infin-
ite number of scenarios and allows for repeated
experiments in the same environment with minimal
risks of cross-contamination. As mentioned before, the
main limitation is SPED inertia against disinfectants.
This proof of concept study has limitations. The con-
ducted experiments were limited in replications and
simulated patient care was a simplified predefined sce-
nario. However, we do not expect a categorically differ-
ent behaviour of SPED in real-life care settings. The
concentration of SPED on consecutive sites was high
enough to rise confidence that even much wider disper-
sal can still be traced. Differences in hand-to-surface ex-
posures, e.g. applied pressure and contact time, in
addition to inhomogeneous distribution of the SPED in
the test solution and slight variations in the swabbing
technique may explain the non-linear decline of recovery
rates from consecutive touch sites as well as the vari-
ation of positive results in the 3 runs. Future work on
SPED tracking should attempt to decrease the technical
variation in recovery. Considering that concentrations of
pathogens (e.g. Norovirus in faeces) appear to be in the
same range [36], our results represent an extreme but
not unrealistic scenario. Future dilution series could help
to establish concentration that are more congruent to
daily healthcare conditions. Finally, given the variation
in SPED recovery in our study, future work could be
invested in standardising the sampling method.
Conclusions
This proof-of-concept study is, to our knowledge, the
first investigation using SPED as a surrogate tracer to
study pathogen transmission in healthcare. Further stud-
ies in various real-life care settings – and modifying
SPED characteristics to align even better with pathogen
features – will show their potential to investigate out-
breaks and endemic infectious risks at a system level.
In conclusion, SPED spread quickly over all the touch-
sites through hand contact and allow to determine their
origin and mimic the transmission of live bacteria. They
represent a convenient and safe tool to explore pathogen
spread from an infinite number of sites simultaneously.
They can be developed further to become a central asset
for a more effective infection prevention in healthcare
and beyond.
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